Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXI7BR
|
||||
Drug Name |
(S)-1-[(2S,4R)-4-(4,6-Dimethoxy-benzo[b]thiophen-2-yl)-2-methyl-piperidin-1-yl]-3-(2-methyl-1H-indol-4-yloxy)-propan-2-ol
|
||||
Synonyms |
CHEMBL128866
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H34N2O4S
|
||||
Canonical SMILES |
COc1cc(OC)c2cc(sc2c1)[C@@H]3CCN(C[C@H](O)COc4cccc5[nH]c(C)cc45)[C@@H](C)C3
|
||||
InChI |
InChI=1S/C28H34N2O4S/c1-17-10-22-24(29-17)6-5-7-25(22)34-16-20(31)15-30-9-8-19(11-18(30)2)27-14-23-26(33-4)12-21(32-3)13-28(23)35-27/h5-7,10,12-14,18-20,29,31H,8-9,11,15-16H2,1-4H3/t18-,19+,20-/m0/s1
|
||||
InChIKey |
JLSJIJYQIHEWKC-ZCNNSNEGSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.